These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 2969099
1. [Anti-ischemic effects of SIN-1, a molsidomine metabolite, during coronary angioplasty and antiplatelet effects in humans]. Darius H, Erbel E, Schmucker B, Reusch U, Meyer J. Presse Med; 1988 May 25; 17(20):1033-6. PubMed ID: 2969099 [Abstract] [Full Text] [Related]
5. [Acute and chronic effects of molsidomine in therapeutic coronary angioplasty]. Darius H, Erbel R, Rupprecht HJ, Pop T, Meyer J. Med Klin (Munich); 1990 Feb 25; 85 Suppl 1():23-6. PubMed ID: 2185404 [Abstract] [Full Text] [Related]
6. [Diameter changes of epicardial coronary arteries and coronary stenoses after intracoronary application of SIN 1, a molsidomine metabolite]. Schulz W, Wendt T, Scherer D, Kober G. Z Kardiol; 1983 Jul 25; 72(7):404-9. PubMed ID: 6613236 [Abstract] [Full Text] [Related]
7. [Role of molsidomine on platelet activation in coronary ischemia]. Wautier JL. Presse Med; 1988 May 25; 17(20):1037-40. PubMed ID: 2969100 [Abstract] [Full Text] [Related]
8. Molsidomine. Reden J. Blood Vessels; 1990 May 25; 27(2-5):282-94. PubMed ID: 2242448 [Abstract] [Full Text] [Related]
11. Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo. Gerzer R, Drummer C, Karrenbrock B, Heim JM. J Cardiovasc Pharmacol; 1989 May 25; 14 Suppl 11():S115-9. PubMed ID: 2484688 [Abstract] [Full Text] [Related]
12. New approach to molsidomine active metabolites coming from the results of 2 models of experimental cardiology. Żorniak M, Mitręga KA, Porc M, Krzemiński TF. Can J Physiol Pharmacol; 2017 Feb 25; 95(2):111-121. PubMed ID: 27918857 [Abstract] [Full Text] [Related]
13. Interaction between SIN-1 and prostacyclin in inhibiting platelet aggregation. Bult H, Fret HR, Herman AG. J Cardiovasc Pharmacol; 1989 Feb 25; 14 Suppl 11():S120-3. PubMed ID: 2484689 [Abstract] [Full Text] [Related]
14. The antiadhesive and antithrombotic effects of the nitric oxide donor SIN-1 are combined with a decreased vasoconstriction in a porcine model of balloon angioplasty. Provost P, Tremblay J, Merhi Y. Arterioscler Thromb Vasc Biol; 1997 Sep 25; 17(9):1806-12. PubMed ID: 9327781 [Abstract] [Full Text] [Related]
16. [Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration]. Hug J, Hasenfuss G, Wollschläger H, Just HJ, Bonzel T. Med Klin (Munich); 1994 Jul 25; 89 Suppl 2():34-7. PubMed ID: 7968899 [No Abstract] [Full Text] [Related]
17. [Effects of intracoronary injection of SIN-1 on vasoconstriction of epicardial arteries induced by acetylcholine]. Dubois-Randé JL, Adnot S, Dupouy P, Castaigne A, Geschwind H. Arch Mal Coeur Vaiss; 1993 Jun 25; 86(6):881-7. PubMed ID: 8274060 [Abstract] [Full Text] [Related]
18. Nitroglycerin-resistant coronary spasm treated with intracoronary linsidomine chlorhydrate (SIN-1). Drobinski G, Montalescot G. Eur Heart J; 1990 May 25; 11(5):472-5. PubMed ID: 2112998 [Abstract] [Full Text] [Related]